Health Care & Life Sciences » Pharmaceuticals | Immune Design Corp.

Immune Design Corp.

Immune Design Corp.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
48.16 M
Public Float
35.18 M
Immune Design Corp.
Stock Exchange NASDAQ Stock Market
EPS
$1.38
Market Cap
$163.76 M
Shares Outstanding
48.17 M
Public Float
28.99 M

Profile

Address
1616 Eastlake Avenue East
Seattle Washington 98102
United States
Employees -
Website http://www.immunedesign.com
Updated 09/14/2018
Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G.

Financials

View All
Created with Highcharts 5.0.14Immune Design Corp.Net Income. Fiscal year is January-December. All values USD Thousands.15 97515 97534 15134 15139 44539 44553 53053 53051 86251 86220132014201520162017010k20k30k40k50k60k
Created with Highcharts 5.0.14Immune Design Corp.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.1 5991 5996 4336 4339 5109 51013 26013 2607 1957 1952013201420152016201702.5k5k7.5k10k12.5k15k

Carlos V. Paya
President, Chief Executive Officer & Director
Ed E. Penhoet
Chairman